- Home
- FBGL vs VYNE Comparison
FBGL vs VYNE Comparison
Compare FBGL & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBGL
- VYNE
- Stock Information
- Founded
- FBGL 1996
- VYNE 2003
- Country
- FBGL Singapore
- VYNE United States
- Employees
- FBGL N/A
- VYNE N/A
- Industry
- FBGL Miscellaneous manufacturing industries
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- FBGL Consumer Discretionary
- VYNE Health Care
- Exchange
- FBGL Nasdaq
- VYNE Nasdaq
- Market Cap
- FBGL 10.5M
- VYNE 9.6M
- IPO Year
- FBGL 2025
- VYNE 2018
- Fundamental
- Price
- FBGL $0.61
- VYNE $0.35
- Analyst Decision
- FBGL
- VYNE Buy
- Analyst Count
- FBGL 0
- VYNE 2
- Target Price
- FBGL N/A
- VYNE $8.00
- AVG Volume (30 Days)
- FBGL 397.9K
- VYNE 3.1M
- Earning Date
- FBGL 11-23-2025
- VYNE 11-10-2025
- Dividend Yield
- FBGL N/A
- VYNE N/A
- EPS Growth
- FBGL N/A
- VYNE N/A
- EPS
- FBGL N/A
- VYNE N/A
- Revenue
- FBGL $10,491,303.00
- VYNE $476,000.00
- Revenue This Year
- FBGL N/A
- VYNE N/A
- Revenue Next Year
- FBGL N/A
- VYNE N/A
- P/E Ratio
- FBGL N/A
- VYNE N/A
- Revenue Growth
- FBGL N/A
- VYNE N/A
- 52 Week Low
- FBGL $0.41
- VYNE $0.28
- 52 Week High
- FBGL $5.45
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- FBGL 49.20
- VYNE 43.93
- Support Level
- FBGL $0.43
- VYNE $0.34
- Resistance Level
- FBGL $0.65
- VYNE $0.38
- Average True Range (ATR)
- FBGL 0.08
- VYNE 0.03
- MACD
- FBGL -0.00
- VYNE -0.00
- Stochastic Oscillator
- FBGL 61.58
- VYNE 19.19
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.